Raymond James Downgrades Acadia Healthcare Co to Outperform, Lowers Price Target to $26
Author: Benzinga Newsdesk | August 14, 2025 06:36am
Raymond James analyst John Ransom downgrades Acadia Healthcare Co (NASDAQ:ACHC) from Strong Buy to Outperform and lowers the price target from $40 to $26.